Results 21 to 30 of about 5,408,282 (157)

Intensity-modulated radiotherapy for a rendu-osler-weber disease patient with recurrent severe epistaxis: a case report. [PDF]

open access: yesCase Rep Med, 2010
We present a case of a Rendu-Osler-Weber disease patient with recurrent life threatening epistaxis demanding multiple blood transfusions despite of repetitive endoscopic laser and electrocoagulations, endovascular embolisation, septodermoplasty, and long-
Niyazi M   +7 more
europepmc   +5 more sources

Rheumatoid arthritis associated with Rendu — Osler — Weber disease: Second description [PDF]

open access: yes, 2021
The article presents second ever published description of rheumatoid arthritis case co-morbid with Rendu — Osler — Weber disease (hereditary hemorrhagic teleangiectasia) in a 63-yearsold female patient.
de Carvalho, Jozélio Freire   +3 more
core   +1 more source

Rotational angiography and the contribution of roadmapping to the occlusion of arteriovenous malformations. How would I approach it?

open access: yesREC: Interventional Cardiology (English Ed.), 2022
HOW WOULD I APPROACH IT? Authors present an interesting case of a 10-year-old with a familial history of Rendu-Osler-Weber disease. The patient shows signs of cyanosis, polyglobulia, and baseline oxygen saturation levels of 85% due to a large and ...
Roberto Blanco Mata
doaj   +1 more source

Ischemic cholangitis during Osler-Weber-Rendu disease: a case report

open access: yesEgyptian Liver Journal, 2022
Background Osler-Weber-Rendu disease (OWRD) is a rare autosomal dominant genetic disease that causes skin and mucosal telangiectasias and visceral arteriovenous malformations.
Oussama Kharmach   +4 more
doaj   +1 more source

Case of Osler-Weber-Rendu Syndrome Complicated with Nasal Septum Perforation

open access: yesCentral Asian Journal of Medical Sciences, 2020
Objectives: Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease) is a rare autosomal dominant disorder characterized by multiple mucocutaneous telangiectasias and visceral arteriovenous malformations.
Odgerel Tsogbadrakh   +4 more
doaj   +1 more source

Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial

open access: yesJournal of Internal Medicine, Volume 294, Issue 6, Page 761-774, December 2023., 2023
Abstract Background Bevacizumab—a humanized monoclonal antibody—has been widely used to treat patients with hereditary hemorrhagic telangiectasia (HHT), but no randomized trial has yet been conducted. Methods This study is a double‐blind multicenter randomized phase 2 trial with a 1:1 active‐treatment‐to‐placebo ratio. We included patients over the age
Sophie Dupuis‐Girod   +25 more
wiley   +1 more source

OSLER – WEBER – RENDU SYNDROME: A RARE CASE OF UPPER GASTROINTESTINAL BLEEDING [PDF]

open access: yes, 2022
BACKGROUND: Osler-Weber-Rendu syndrome (Hereditary hemorrhagic telengiectasia) cases present with recurrent epistaxis, gastrointestinal bleeding (hematemesis, melena), and arteriovenous malformations involving almost all organs of body.
Muhammad Ahmed Khan   +2 more
core   +1 more source

Massive Hemothorax by Ruptured Arteriovenous Malformation [PDF]

open access: yesModern Medicine
Introduction and objectives: Osler Weber Rendu disease is a rare genetic disorder characterized by multiple telangiectasias and arteriovenous malformations involving parenchymatous organs, leading to hemorrhagic, sometimes life threatening vascular ...
Genoveva CADAR, Otilia RADU
doaj   +1 more source

Osler-Weber-Rendu Syndrome: A Case Report With Familial Clustering [PDF]

open access: yes, 2009
Osler-Weber-Rendu syndrome, also known as hereditary hemorrhagic telangiectasia, is a rare autosomal dominant disorder manifested by telangiectases of the skin and mucous membranes and arteriovenous malformations of various organ systems.
Sahni, H.   +5 more
core   +2 more sources

Hereditary Hemorrhagic Telangiectasia

open access: yesPediatric Neurology Briefs, 1998
Hereditary Hemorrhagic Telangiectasia (HHT), also known as Osler-Weber-Rendu disease, was the subject of an NIH workshop, organized by the National Heart, Lung, and Blood Institute, on July 10-11, 1997.
J Gordon Millichap
doaj   +1 more source

Home - About - Disclaimer - Privacy